Search

Showing 15 of 86 Results

August 5, 2022News Article
Gates MRI's Head of Therapeutics Development, Charles Wells, gave an interview with News Medical in which he discussed our current research into tuberculosis, the World Health Organization's new guidelines for TB care, and what inspired his career. He also spoke about Gates MRI's novel potential vaccine interventions and how we're supporting future innovative approaches to TB treatment.
As Head of Global Regulatory Strategy and Operations at the Bill & Melinda Gates Medical Research Institute, Dakshina Reddy, MSc, and his team develops and implements innovative global regulatory strategies that support accelerated product development, playing a critical role in helping to advance drug and vaccine candidates toward licensure globally.
Access Supplier Training Training Section Recaps CSP Overview & Navigation Purchase Order and Invoice Processing (CSP) Purchase Order and Invoice Processing (SAN) Supplier Information Management (SIM) CSP: Coupa Supplier Portal SAN: Supplier Actionable Notification NEED MORE INFORMATION OR HELP USING COUPA?…
September 7, 2021Publication
Gates MRI’s Research Project Manager, Judith Maxwell Silverman, contributed to research demonstrating how a bioengineered yeast production strain combined with an optimized version of the SARS-CoV-2 spike protein receptor-binding domain (RBD) exhibits improved biomolecular attributes that are well-suited for further development for large-volume manufacturing of low-cost vaccine candidate.
As Head of Finance at the Bill & Melinda Gates Medical Research Institute, Harish Kaushal, MBA, CPA, oversees the continuous improvement and growth of Gates MRI’s financial operations. Harish brings more than 20 years of Finance leadership experience in pharmaceuticals and health-tech helping businesses set strategy, accelerate revenue growth, drive…
We are committed to a paperless source-to-pay process, enabled by Coupa. Coupa is a cloud-based business spend management tool with an easy-to-use interface that will make it easier for suppliers to interact with Gates MRI. This digital solution will help manage Gates MRI’s procurement processes (sourcing, contracting, purchasing,…
September 15, 2021Publication
Gates MRI’s Chief Medical Officer and Head of Development, Michael Dunne; Program Lead Mohamed Bassyouni; Head of Global Regulatory Strategy & Operations, Taryn Rogalski-Salter; Head of Translational Discovery, Jared Silverman; and Program Leads Jeroen Medema and Mohamed Bassiouni investigated whether rivaroxaban, a direct oral anticoagulant factor Xa inhibitor, would reduce coronavirus disease 2019 (COVID-19) progression.